You searched for metabolic diseases - Page 39 of 63

News and Trends 13 Jul 2022

Sanofi sells two portfolios of established products to Neuraxpharma

…in pain and vascular diseases. Following the acquisition of these new portfolios, Neuraxpharm’s annual gross sales will be around €0.6 billion. Spectrum of diseases The products are targeted for patients…

July 13, 2022 - 2 minutesmins - By Liza Laws

News and Trends 14 Nov 2022

Early diagnosis tool for childhood kidney disease

…develop new urine tests that can catch the disease earlier, as well as the development of similar tests for other diseases. Filtration Kidneys are our body’s essential filtration system. The…

November 14, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 18 Mar 2025

Cancer vaccines: 11 biotechs to keep an eye out for

…Situated in the brimming biotech hub in Cambridge, Massachusetts, Elicio Therapeutics specializes in immunotherapeutic research in the field of cancer and infectious diseases. And its amphiphile technology (AMP) platform is…

March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter

In Depth 26 Mar 2025

A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations

…implicated in numerous diseases, particularly cancer. This is where kinase inhibitors come into play. Kinases have become one of the most extensively targeted enzymes in drug development. While traditional chemotherapies…

March 26, 2025 - 9 minutesmins - By Jules Adam

Podcast 12 Jan 2024

Could natural killer cells transform Alzheimer’s treatment?

…various diseases, whether it be autoimmune diseases or cancer susceptibility, is there a therapy for that?” Song said. So, the company set about developing a natural killer cell therapy to…

January 12, 2024 - 6 minutesmins - By Jim Cornall

News and Trends 6 Jan 2023

BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies

…diseases affecting collectively hundreds of millions of people worldwide. If successful, this collaboration has the potential to improve outcomes for patients and provide early access to our suite of cancer…

January 6, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 13 Mar 2017

This Dutch Company is Upgrading ADCs for Immunotherapy

…Xenikos, in 2009 to further refine T-Guard as a treatment for acute graft-versus-host disease (GVHD) and other orphan diseases. We talked to him about his technology and company outlook. What…

March 13, 2017 - 7 minutesmins - By External Contributor

News and Trends 23 Jul 2018

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

…focussed biotechs are combating cancer, TxCell is going one step further by developing CAR-T therapies for autoimmune diseases using a different type of CAR-T cell. Usually, CAR-T therapies use killer…

July 23, 2018 - 3 minutesmins - By Alexander Burik

liver anatomy organs Sebastian Kaulitzki fi

News and Trends 21 Nov 2016

“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”

…Regarding R&D, our territory is expanding from rare diseases to immune modulation using our mesenchymal stem cells (MSC’s). Our MSC’s are called HepaStem, which were originally used for UCD for…

November 21, 2016 - 7 minutesmins - By Evelyn Warner

News and Trends 24 Jan 2023

Ubiquigent and University of Glasgow to collaborate on drug discovery

…University of Glasgow (UoG) to undertake a research project on USP30, a DUB implicated in neruodegenerative, renal, and cardiovascular diseases. Overseen by structural biology experts Helen Walden, UoG, and Mehmet…

January 24, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 21 Apr 2023

RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy

…patient outcomes in geographic atrophy (GA) by combining RetinAI’s Discovery platform and AI tools with Boehringer Ingelheim’s research in retinal diseases. GA is a progressive, advanced form of age-related macular…

April 21, 2023 - 2 minutesmins - By Jim Cornall

Interview 31 Aug 2022

How CDMOs keep pace with trends in advanced therapies

…for protein-based therapeutics. The intracellular mode of action is expected to allow the treatment of diseases that so far could not be tackled, such as genetic diseases where patients lack…

August 31, 2022 - 8 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Sanofi sells two portfolios of established products to Neuraxpharma

Early diagnosis tool for childhood kidney disease

Cancer vaccines: 11 biotechs to keep an eye out for

A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations

Could natural killer cells transform Alzheimer’s treatment?

BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies

This Dutch Company is Upgrading ADCs for Immunotherapy

Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease

“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”

Ubiquigent and University of Glasgow to collaborate on drug discovery

RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy

How CDMOs keep pace with trends in advanced therapies

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!